Skip to content
Bored Studies
RecruitingPhase 3

Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy

Vertanical GmbH · NCT06956014

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Phase 3
Target enrollment
810
US sites recruiting
23
Study start
September 22, 2026
Record last updated
October 21, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not led to sufficient pain relief or were unsuitable due to contraindications or intolerance.

Being studied: VER-01; Placebo

Conditions: Lumbosacral Radiculopathy

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Participants ≥ 18 years of age, all sexes
  • Participant voluntarily provided written informed consent
  • Participant is willing and able to comply with scheduled visits, treatment plan, eDiary, and other trial-related procedures throughout trial participation

Exclusion Criteria

  • Pregnant or breastfeeding female patients
  • Known history of previous or current severe psychiatric disorder as per DSM-5 (e.g., schizophrenia, bipolar disorder, severe anxiety disorder, psychotic disorder, post-traumatic stress disorder), or currently taking antipsychotic medication
  • Cardiovascular event or clinically significant cardiac dysfunction (e.g., congestive heart failure, myocardial ischemia, arrhythmias, poorly controlled high blood pressure, congenital long QT syndrome) within 12 months or a cardiac disorder that, in the opinion of the investigator, would put the patient at risk of a clinically significant arrhythmia or myocardial infarction

Recruiting US locations

  • AMR Mobile

    Mobile, AL 36608

    Site contact: Harry Studdard · 251-414-1984 · harry.studdard@amr-clinical.com

  • Alliance for Multispecialty Research - Tempe I

    Tempe, AZ 85281

    Site contact: William Reedy · 602-910-3343 · William.Reedy@amr-clinical.com

  • Central Medical Research Institute

    Long Beach, CA 90802

    Site contact: Kyle Tent · 562-455-6767 · kyle@cmrillc.com

  • Bradenton Research Center

    Bradenton, FL 34205

    Site contact: Eric Folkens · 941-708-0005 · info@bradentonresearch.com

  • Green Leaf Clinical Trials

    Jacksonville, FL 32258

    Site contact: Nicole Gilyard · 904-680-2818 · ngilyard@greenleafclinicaltrials.com

  • Floridian Research Institute LLC I

    Miami, FL 33179

    Site contact: Jose Fidalgo · 786-391-1137 · jmfidalgo@floridianresearch.com

  • Alma Clinical Research

    Miami, FL 33184

    Site contact: Rogelio B Rodriguez · 786-762-2922 · rbardinas@almaresearch1.com

  • Conquest Research - Lake Nona

    Orlando, FL 32832

    Site contact: Kendra Tandeski · 407-916-0060 · info@conquestresearch.com

  • Alfa Medical Research - Pembroke Pines

    Pembroke Pines, FL 33029

    Site contact: Claudia Ramirez · 754-263-3626 · cramirez@alfamedicalgroups.com

  • United Medical Research

    Port Orange, FL 32738

    Site contact: Tasha Brocato · 386-304-7070 · tashab@progressivemedicalresearch.com

  • Conquest Research - Winter Park

    Winter Park, FL 32789

    Site contact: James Kelly · 407-916-0060 · james.kelly@conquestresearch.com

  • Alliance for Multispecialty Research - Wichita East

    Wichita, KS 67226

    Site contact: Terry Klein · 316-689-6635 · terry.klein@amr-clinical.com

  • Monroe Biomedical Research - Monroe

    Monroe, NC 28112

    Site contact: MBR Recruitment Team · 704-290-3556 · JoinUs@MonroeResearch.com

  • Progressive Medicine of the Triad, LLC

    Winston-Salem, NC 27103

    Site contact: Donna Rice · 336-768-3456 · drice@progressivemedicineofthetriad.com

  • Velocity Clinical Research - Cleveland

    Cleveland, OH 44122

    Site contact: Elizabeth Schneider · 216-682-0320 · eschneider@velocityclinical.com

  • Epic Medical Research - Chickasha

    Chickasha, OK 73018

    Site contact: Daniel Duncan · 512-480-9660 · dduncan@ctcrcorp.com

  • Clinitiative - Clinical Trials of South Carolina - Charleston

    Charleston, SC 29406

    Site contact: Rhiannon Crump · 843-789-3707 · rhenderson@clinicaltrialssc.com

  • Alliance for Multispecialty Research - Knoxville

    Knoxville, TN 37920

    Site contact: William Smith · 865-305-9100 · william.smith@amr-clinical.com

  • R & H Clinical Research

    Katy, TX 77494

    Site contact: Esmeralda Aguirre · 832-345-5316 · esmeralda@rhclinicalresearch.com

  • Epic Clinical Research - Lewisville

    Lewisville, TX 75057

    Site contact: Jessica Powell · 469-361-8007 · jpowell@allianceclinicalnetwork.com

  • Grayline Research Center

    Wichita Falls, TX 76309

    Site contact: Kathy Castro · 940-322-1131 · kcastro@graylinecdt.com

  • Boeson Research

    Provo, UT 84604

    Site contact: Melissa Loosli · 385-392-2200 · pvustaff@boesonresearch.com

  • CenExel JBR - Salt Lake City

    Salt Lake City, UT 84107

    Site contact: Todd Bertoch · 801-261-2000 · t.bertoch@cenexel.com

Study contacts (from the official record)

  • Vertanical GmbH · +49 (0)89 787 97 90 - 0202 · regulatory@vertanical.com
All pain studies in Alabama →
Efficacy and Safety of VER-01 in the Treatment of Participants… (NCT06956014) | Bored Studies